Astellas Pharma Inc.

OTC: ALPMF · Real-Time Price · USD
11.10
0.00 (0.00%)
At close: Aug 08, 2025, 2:03 PM

Astellas Pharma Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Cash & Equivalents
188.37B 335.69B 376.84B 315.99B 326.13B
Short-Term Investments
29.94B 28.78B 19.78B 21.3B 5.56B
Long-Term Investments
18.99B 163.02B 145.03B 141.21B 146.8B
Other Long-Term Assets
153.25B 45.59B 1M -1M -1M
Receivables
632.52B 534.99B 427.96B 382.46B 343.18B
Inventory
297.26B 248.74B 174.39B 153.07B 164.08B
Other Current Assets
53.25B 46.54B 70.76B 71.83B 39.2B
Total Current Assets
1,201.3B 1,194.7B 1,050B 923.35B 872.59B
Property-Plant & Equipment
328.92B 293.74B 286.46B 269.04B 264.62B
Goodwill & Intangibles
1,538.9B 1,872.5B 890.91B 926.46B 935.44B
Total Long-Term Assets
2,138.2B 2,374.9B 1,406.6B 1,409B 1,401B
Total Assets
3,339.5B 3,569.6B 2,456.5B 2,332.4B 2,273.6B
Account Payables
187.84B 185.19B 140.24B 130.74B 124.78B
Deferred Revenue
n/a n/a -88.55B -157.73B -136.1B
Short-Term Debt
266.53B 472.28B 75B n/a 120B
Other Current Liabilities
572.69B 458.08B 366.98B 420.12B 222.7B
Total Current Liabilities
1,061.6B 1,285.7B 726.03B 687.41B 592.37B
Long-Term Debt
564.89B 447.74B 50B n/a 80.4B
Other Long-Term Liabilities
194.43B 240.15B 51.25B 45.73B 50.94B
Total Long-Term Liabilities
764.68B 687.89B 222.53B 184.68B 295.14B
Total Liabilities
1,826.3B 1,973.6B 948.56B 872.09B 887.51B
Total Debt
831.43B 1,005.7B 200.01B 212.74B 278.26B
Common Stock
103B 103B 103B 103B 103B
Retained Earnings
740.94B 809.4B 908.16B 944.26B 953.29B
Comprehensive Income
n/a n/a 340.64B 247.51B 167.37B
Shareholders Equity
1,513.3B 1,596B 1,508B 1,460.3B 1,386.1B
Total Investments
18.99B 124.38B 110.58B 101.88B 102.97B